Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1968 Jan;23(1):94–99. doi: 10.1136/thx.23.1.94

Treatment of unclassified mycobacterial infection of the lungs

K P Goldman 1,1
PMCID: PMC471740  PMID: 5637506

Abstract

In a review of 25 patients with pulmonary infection caused by unclassified mycobacteria the course of the disease is related to the method of treatment. Five patients were followed while not being treated; in four the disease progressed and in one it remained static, and in each case the organism persisted in the sputum. Sixteen patients were given combinations of streptomycin, isoniazid, and para-aminosalicylic acid for periods which varied between three months and two and a half years; there was bacteriological sputum conversion in six, although in each case the organism showed in vitro resistance to these drugs. Eleven patients were treated primarily with combinations of other anti-tuberculosis drugs for at least 12 consecutive weeks, after which the mycobacteria could no longer be cultured from the sputum in eight, in each case the organism showing in vitro sensitivity to the drugs. Ten patients received combined medical and surgical treatment, which was successful in eight and a failure in two, one of whom died post-operatively. A favourable response occurred most frequently when the disease was confined to one pulmonary radiographic zone and when less than 10 positive sputum cultures had been obtained. These results show that in this type of disease the response to chemotherapy is uncertain, in vitro drug sensitivity tests are of limited value, and combined medical and surgical treatment is usually effective.

Full text

PDF
94

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CORPE R. F. CLINICAL ASPECTS, MEDICAL AND SURGICAL, IN THE MANAGEMENT OF BATTEY-TYPE PULMONARY DISEASE. Dis Chest. 1964 Apr;45:380–382. doi: 10.1378/chest.45.4.380. [DOI] [PubMed] [Google Scholar]
  2. CORPE R. F., RUNYON E. H., LESTER W. Status of disease due to unclassified mycobacteria. A statement of the Subcommittee on Unclassified Mycobacteria of the Committee on Therapy. Am Rev Respir Dis. 1963 Mar;87:459–461. doi: 10.1164/arrd.1963.87.3P1.459. [DOI] [PubMed] [Google Scholar]
  3. HARRISON R. W., REIMANN A. F., LONG E. T., LESTER W., Jr, ADAMS W. E. Adverse surgical experience in the treatment of pulmonary disease caused by atypical acid-fast bacilli. J Thorac Cardiovasc Surg. 1959 Oct;38:481–500. [PubMed] [Google Scholar]
  4. KAMAT S. R., ROSSITER C. E., GILSON J. C. A retrospective clinical study of pulmonary disease due to "anonymous mycobacteria" in Wales. Thorax. 1961 Sep;16:297–308. doi: 10.1136/thx.16.3.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LEWIS A. G., Jr, LASCHE E. M., ARMSTRONG A. L., DUNBAR F. P. A clinical study of the chronic lung disease due to nonphotochromogenic acid-fast bacilli. Ann Intern Med. 1960 Aug;53:273–285. doi: 10.7326/0003-4819-53-2-273. [DOI] [PubMed] [Google Scholar]
  6. PHILLIPS S., LARKIN J. C., Jr ATYPICAL PULMONARY TUBERCULOSIS CAUSED BY UNCLASSIFIED MYCOBACTERIA. Ann Intern Med. 1964 Mar;60:401–408. doi: 10.7326/0003-4819-60-3-401. [DOI] [PubMed] [Google Scholar]
  7. RUNYON E. H. Anonymous mycobacteria in pulmonary disease. Med Clin North Am. 1959 Jan;43(1):273–290. doi: 10.1016/s0025-7125(16)34193-1. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES